1. AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study
   Zhe Cao et al, 2022, Frontiers in Oncology CrossRef
2. Diagnostic value of aldo‑keto reductase family 1 member B10 in human nasopharyngeal carcinoma
   Jinping Lu et al, 2023, Molecular and Clinical Oncology CrossRef
3. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
   Marko Hojnik et al, 2021, Cancers CrossRef
4. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
   Marko Hojnik et al, 2022, Cancers CrossRef
5. A Novel lncRNA lncRNA-4045 Promotes the Progression of Hepatocellular Carcinoma by Affecting the Expression of AKR1B10
   Chao Tan et al, 2024, Digestive Diseases and Sciences CrossRef
6. The Role of AKR1B10 in Physiology and Pathophysiology
   Satoshi Endo et al, 2021, Metabolites CrossRef